A citation-based method for searching scientific literature

Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen, Olufunmilayo I Olopade. JAMA 2005
Times Cited: 171







List of co-cited articles
818 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
222
20

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
628
20

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
19

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
18

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
224
17

Breast cancer genetics in African Americans.
Olufunmilayo I Olopade, James D Fackenthal, Georgia Dunston, Michael A Tainsky, Francis Collins, Carolyn Whitfield-Broome. Cancer 2003
110
15

Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
Kathleen E Malone, Janet R Daling, David R Doody, Li Hsu, Leslie Bernstein, Ralph J Coates, Polly A Marchbanks, Michael S Simon, Jill A McDonald, Sandra A Norman,[...]. Cancer Res 2006
211
15

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
284
15

Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
Q Gao, G Tomlinson, S Das, S Cummings, L Sveen, J Fackenthal, P Schumm, O I Olopade. Hum Genet 2000
79
18

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
14


Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
122
13

Inherited predisposition to breast cancer among African American women.
Jane E Churpek, Tom Walsh, Yonglan Zheng, Zakiya Moton, Anne M Thornton, Ming K Lee, Silvia Casadei, Amanda Watts, Barbara Neistadt, Matthew M Churpek,[...]. Breast Cancer Res Treat 2015
84
14

BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Kristen J Vogel, Deann P Atchley, Julie Erlichman, Kristine R Broglio, Kaylene J Ready, Vicente Valero, Christopher I Amos, Gabriel N Hortobagyi, Karen H Lu, Banu Arun. J Clin Oncol 2007
47
23

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
James D Fackenthal, Olufunmilayo I Olopade. Nat Rev Cancer 2007
283
11

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
10

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, D F Easton, C Evans, J Deacon, M R Stratton. J Natl Cancer Inst 1999
633
10

Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
Tuya Pal, Devon Bonner, Jongphil Kim, Alvaro N A Monteiro, Lisa Kessler, Robert Royer, Steven A Narod, Susan T Vadaparampil. Breast J 2013
26
38

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
9


Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Kathy S Albain, Joseph M Unger, John J Crowley, Charles A Coltman, Dawn L Hershman. J Natl Cancer Inst 2009
324
9


The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
S R Young, Robert T Pilarski, Talia Donenberg, Charles Shapiro, Lyn S Hammond, Judith Miller, Karen A Brooks, Stephanie Cohen, Beverly Tenenholz, Damini Desai,[...]. BMC Cancer 2009
169
9

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
437
9

Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.
Dezheng Huo, Ruby T Senie, Mary Daly, Saundra S Buys, Shelly Cummings, Jacqueline Ogutha, Kisha Hope, Olufunmilayo I Olopade. J Clin Oncol 2009
32
28

Performance of BRCA1/2 mutation prediction models in Asian Americans.
Allison W Kurian, Gail D Gong, Nicolette M Chun, Meredith A Mills, Ashley D Staton, Kerry E Kingham, Beth B Crawford, Robin Lee, Salina Chan, Susan S Donlon,[...]. J Clin Oncol 2008
43
20

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
9

Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
Rachel Greenup, Adam Buchanan, Wendy Lorizio, Keelia Rhoads, Salina Chan, Tracey Leedom, Robin King, Jane McLennan, Beth Crawford, P Kelly Marcom,[...]. Ann Surg Oncol 2013
122
9

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.
James D Fackenthal, Jing Zhang, Bifeng Zhang, Yonglan Zheng, Fitsum Hagos, Devin R Burrill, Qun Niu, Dezheng Huo, Walmy E Sveen, Temidayo Ogundiran,[...]. Int J Cancer 2012
55
16

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
8

BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.
Tuya Pal, Jenny Permuth-Wey, Tricia Holtje, Rebecca Sutphen. Cancer Epidemiol Biomarkers Prev 2004
42
19

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.
B G Haffty, D H Choi, S Goyal, A Silber, K Ranieri, E Matloff, M H Lee, M Nissenblatt, D Toppmeyer, M S Moran. Ann Oncol 2009
38
21

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
8

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
8

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
313
8

The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Wen-Feng Li, Zhen Hu, Nan-Yan Rao, Chuang-Gui Song, Bin Zhang, Ming-Zhi Cao, Feng-Xi Su, Yong-Sheng Wang, Ping-Qing He, Gen-Hong Di,[...]. Breast Cancer Res Treat 2008
77
10

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
117
8

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
8

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
836
8

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.
Lisa R Susswein, Cécile Skrzynia, Leslie A Lange, Jessica K Booker, Mark L Graham, James P Evans. J Clin Oncol 2008
42
19

Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Julie R Palmer, Edward A Ruiz-Narvaez, Charles N Rotimi, L Adrienne Cupples, Yvette C Cozier, Lucile L Adams-Campbell, Lynn Rosenberg. Cancer Epidemiol Biomarkers Prev 2013
63
12

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
8

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
322
8

Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
8

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
51
15

Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.
Lisa A Newman, Kent A Griffith, Ismail Jatoi, Michael S Simon, Joseph P Crowe, Graham A Colditz. J Clin Oncol 2006
247
7

The genetic attributable risk of breast and ovarian cancer.
E B Claus, J M Schildkraut, W D Thompson, N J Risch. Cancer 1996
506
7

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
B Newman, H Mu, L M Butler, R C Millikan, P G Moorman, M C King. JAMA 1998
289
7

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
7

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
346
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.